We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00004317
Recruitment Status : Recruiting
First Posted : October 19, 1999
Last Update Posted : May 14, 2009
University of Chicago
Information provided by:
Office of Rare Diseases (ORD)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2030
  Estimated Study Completion Date : December 2030